Literature DB >> 2472341

Hepatic enzymic zonation: a reevaluation of the concept of the liver acinus.

W H Lamers1, A Hilberts, E Furt, J Smith, G N Jonges, C J van Noorden, J W Janzen, R Charles, A F Moorman.   

Abstract

The distribution pattern of a periportal enzyme (carbamoylphosphate synthetase) and a pericentral enzyme (glutamine synthetase) in human and rat liver has provided an objective parameter to delineate the zonal boundaries of the liver acinus. On sections, the pericental zone (zone 3) is circular and discrete rather than star-like and reticular, as predicted by the acinar concept, whereas the periportal zone (zone 1) is reticular, i.e. contiguous between adjacent acini rather than discrete. Three-dimensionally, the composite of pericentral zones (the pericentral compartment) follows the branching pattern of the terminal hepatic (central) vein, whereas the composite of periportal zones (the periportal compartment) envelops the pericentral compartment as a three-dimensional network (reticulum). This modified concept that is based upon the three-dimensional distribution of hepatocyte-specific enzymes is supported by data from the literature regarding the three-dimensional angioarchitecture of the liver, the perfusion pattern of the liver and the three-dimensional pattern of tissue oxygenation. Hence, a unified concept of the liver architecture that is based upon the observed distribution pattern of blood flow, of gene expression and of metabolism can be established.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2472341     DOI: 10.1002/hep.1840100115

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  23 in total

1.  Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systems.

Authors:  Felipe T Lee-Montiel; Subin M George; Albert H Gough; Anup D Sharma; Juanfang Wu; Richard DeBiasio; Lawrence A Vernetti; D Lansing Taylor
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-14

2.  Assessment and histological analysis of the IPRL technique for sequential in situ liver biopsy.

Authors:  Anthony Rowe; Lillian Zhang; Azmena Hussain; Filip Braet; Iqbal Ramzan
Journal:  Comp Hepatol       Date:  2011-08-08

Review 3.  Nitrogen metabolism in liver: structural and functional organization and physiological relevance.

Authors:  D Haüssinger
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

4.  Peri- and postnatal changes in reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase content in hepatocytes of rats.

Authors:  J Watanabe; Y Asaka; S Kanamura
Journal:  Histochem J       Date:  1996-07

Review 5.  Liver zonation: Novel aspects of its regulation and its impact on homeostasis.

Authors:  Rolf Gebhardt; Madlen Matz-Soja
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 6.  Heterogeneity of kinetic parameters of enzymes in situ in rat liver lobules.

Authors:  C J Van Noorden; G N Jonges
Journal:  Histochem Cell Biol       Date:  1995-02       Impact factor: 4.304

Review 7.  Analysis of enzyme reactions in situ.

Authors:  C J Van Noorden; G N Jonges
Journal:  Histochem J       Date:  1995-02

8.  Intralobular heterogeneity of perisinusoidal stellate cells in porcine liver.

Authors:  K Wake; T Sato
Journal:  Cell Tissue Res       Date:  1993-08       Impact factor: 5.249

9.  Direct visualization of functional heterogeneity in hepatobiliary metabolism using 6-CFDA as model compound.

Authors:  Chih-Ju Lin; Feng-Chieh Li; Yu-Yang Lee; Te-Yu Tseng; Wei-Liang Chen; Vladimir Hovhannisyan; Ning Kang; Nicholas G Horton; Shu-Jen Chiang; Chris Xu; Hsuan-Shu Lee; Chen-Yuan Dong
Journal:  Biomed Opt Express       Date:  2016-08-19       Impact factor: 3.732

10.  Rat hepatocarcinogenesis induced by N-nitrosodiethylamine and N-nitrosomorpholine continuously administered at low doses. From basophilic areas of hepatocytes to hepatocellular tumors.

Authors:  C Cortinovis; F Klimek; E Nogueira
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.